Stay updated on Open-Label Safety Study of AXS-05 in Depression Clinical Trial
Sign up to get notified when there's something new on the Open-Label Safety Study of AXS-05 in Depression Clinical Trial page.

Latest updates to the Open-Label Safety Study of AXS-05 in Depression Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe NIH-wide banner announcing terminology changes and linking to transition updates and FAQs is no longer displayed.SummaryDifference1%

- Check19 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check26 days agoChange DetectedA sitewide notice announces an NIH transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe displayed site revision changes from v3.7.0 to v3.7.1, while the page continues to show a 403 error.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previously visible study details with an access-denied message. This indicates the page is currently inaccessible and prevents viewing the study information.SummaryDifference17%

Stay in the know with updates to Open-Label Safety Study of AXS-05 in Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Open-Label Safety Study of AXS-05 in Depression Clinical Trial page.